Skip to main navigation Skip to search Skip to main content

Early F-18-FDHT PET/CT as a predictor of treatment response in mCRPC treated with enzalutamide.

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)232-232
Number of pages1
JournalJournal of Clinical Oncology
Volume37
Issue number7_Suppl
DOIs
Publication statusPublished - 1-Mar-2019
EventASCO-SITC Clinical Immuno-Oncology Symposium - San Francisco, Canada
Duration: 28-Feb-20192-Mar-2019

Cite this